Aydın KANT, Ercan AYDIN, Hülya KILIÇ YILMAZ, Gürdal YILMAZ

COVID-19 HASTALARINDA KARDİYAK TROPONİN-I’NIN CİNSİYET İLİŞKİLİ PROGNOSTİK DEĞERİ

Amaç: Kardiyak troponinler kardiyak ve non-kardiak birçok hastalıkta yükselebilmektedir. Çalışmamızda COVID-19 hastalarının hastaneye kabulünde kardiyak troponin-I seviyesinin yoğun bakım ihtiyacı ve tüm nedenlere bağlı mortalite riskini önceden tahmin etme kabiliyetinin belirlenmesi ve cinsiyet ile ilişkisinin değerlendirilmesi amaçlanmıştır.

Anahtar Kelimeler:

COVID-19, Troponin I, Prognoz

Gender-Related Prognostic Value of Cardiac Troponin-I in Covid-19 Patients

Objective: Cardiac troponin levels can be increased in many cardiac and non-cardiac diseases. In our study, we aimed to measure the troponin-I level of COVID-19 patients at admission to the hospital to determine its ability to predict the intensive care need and all-cause mortality risk and to evaluate its relationship with gender.

Keywords:

COVID-19, Troponin I, Prognosis,

PDF

___

1. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001;286(19):2405-12.
2. Lazzeri C, Bonizzoli M, Cianchi G, Gensini GF, Peris A. Troponin I in the intensive care unit setting: from the heart to the heart. Intern Emerg Med. 2008;3(1):9-16.
3. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335(18):1342-9.
4. Ozsu S, Yilmaz G, Yilmaz I, Oztuna F, Bulbul Y, Ozlu T. C-reactive protein alone or combined with cardiac troponin T for risk stratification of respiratory intensive care unit patients. Respir Care. 2011;56(7):1002-8.
5. Lorson W, Veve MP, Heidel E, Shorman MA. Elevated troponin level as a predictor of inpatient mortality in patients with infective endocarditis in the Southeast United States. BMC Infect Dis. 2020;20(1):24.
6. Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac troponin for assessment of myocardial ınjury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244-58.
7. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197‐204.
8. Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32(4):404-11.
9. Kociol R, Pang P, Gheorghiade M, Fonarow G, O'Connor C, Felker G. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;56(14):1071‐8.
10. Freda B, Tang W, Van Lente F, Peacock W, Francis G. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol. 2002;40(12):2065‐71.
11. Cordeanu EM, Duthil N, Severac F, Lambach H, Tousch J, Jambert L et al. Prognostic value of troponin elevation in COVID-19 hospitalized patients. J Clin Med. 2020;9(12):4078.
12. Majure DT, Gruberg L, Saba SG, Kvasnovsky C, Hirsch JS, Jauhar R; Northwell Health COVID-19 Research Consortium. Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury. Am J Cardiol. 2021;138:100-6.
13. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524.
14. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29.
15. Walter LA, McGregor AJ. Sex- and gender-specific observations and implications for COVID-19. West J Emerg Med. 2020;21(3):507-9.